Condition: Coronary Arterial Disease (CAD) · Sponsor: University of Florida
The primary aim of this study is to determine rates of patients with optimal platelet reactivity range, defined as PRU levels between 85 and 208, when using a (PFT)-guided titration of cangrelor infusion rate (cangrelor titration) compared to 0.75 mcg/kg/min (standard-dose infusion) for bridging.
This description comes directly from the study's public registry record.
Luis Ortega-Paz, MD, PhD · 904-244 2060 · Luis.Ortega@jax.ufl.edu
Andrea Burton, MPH, CCRP · 904-244-5617 · Andrea.Burton@jax.ufl.edu
Always discuss trial participation with your own doctor first.
| University of Florida Jacksonville | Jacksonville, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07225842